Treatment of therapy-resistant sarcoidosis with adalimumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of therapy-resistant sarcoidosis with adalimumab

Published:2005-10-25 Issue:4 Volume:25 Page:596-597
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Callejas-Rubio José Luis,Ortego-Centeno Norberto,Lopez-Perez Lourdes,Benticuaga Maria Nicolas

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s10067-005-0037-9.pdf

Reference9 articles.

1. Seitzer U, Swider C, Stüber F, Suchnicki K, Lange A, Ritcher E et al (1997) Tumour necrosis factor α promoter gene polymorphism in sarcoidosis. Cytokine 9:787–790

2. Mohan VP, Scanga CA, Yu K, Scott HM, Tanaka KE, Tsang E et al (2001) Effects of tumor necrosis factor α on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect Immun 69:1847–1855

3. Yee AMF, Pochapin MB (2001) Treatment of complicated sarcoidosis wit infliximab anti-tumor necrosis factor-α therapy. Ann Intern Med 135:27–31

4. Baughman RP, Lower EF (2001) Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 18:70–74

5. Utz JP, Limper AH, Kalra S, Specks U, Scott JP, Vulk-Pavlovic Z et al (2003) Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest 124:177–185

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Musculoskeletal Manifestations of Sarcoidosis;Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders;2022-01

2. Posterior Segment Sarcoidosis;Albert and Jakobiec's Principles and Practice of Ophthalmology;2022

3. A Primer on the Clinical Aspects of Sarcoidosis for the Basic and Translational Scientist;Journal of Clinical Medicine;2021-06-28

4. Biologics in dermatology: Off-label indications;Indian Dermatology Online Journal;2020

5. Posterior Segment Sarcoidosis;Albert and Jakobiec's Principles and Practice of Ophthalmology;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3